Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2010-06-25

Clinical Trial Update: Proposal to Evaluate the Efficacy of the InterX 5000 in the Treatment of Chronic Neck and Shoulder Pain [Phase 2]

View source ↗

Summary

This document reports a completed Phase 2 proposal to evaluate the efficacy of the InterX 5000 device for chronic neck and shoulder pain.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Drugs mentioned

  • InterX 5000

Snippet

Sponsor: Hamilton Health Sciences Corporation | Conditions: Neck Pain, Shoulder Pain | Phase 2 | Status: COMPLETED